Hemenway Trust Co LLC Sells 555 Shares of Colgate-Palmolive (NYSE:CL)

Hemenway Trust Co LLC trimmed its position in Colgate-Palmolive (NYSE:CLFree Report) by 10.9% in the 3rd quarter, Holdings Channel.com reports. The fund owned 4,530 shares of the company’s stock after selling 555 shares during the quarter. Hemenway Trust Co LLC’s holdings in Colgate-Palmolive were worth $470,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of CL. Price T Rowe Associates Inc. MD grew its stake in shares of Colgate-Palmolive by 27.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after acquiring an additional 8,933,912 shares during the last quarter. Swedbank AB acquired a new position in Colgate-Palmolive during the 1st quarter valued at approximately $286,370,000. Acadian Asset Management LLC raised its holdings in shares of Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock worth $551,367,000 after buying an additional 2,955,442 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Colgate-Palmolive by 40.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after buying an additional 2,593,313 shares during the last quarter. Finally, Ossiam increased its position in shares of Colgate-Palmolive by 368.4% in the 1st quarter. Ossiam now owns 1,563,768 shares of the company’s stock valued at $140,817,000 after acquiring an additional 1,229,891 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

CL has been the topic of several recent research reports. Sanford C. Bernstein upped their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a report on Tuesday, July 30th. JPMorgan Chase & Co. raised their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. HSBC reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Piper Sandler started coverage on shares of Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price target on the stock. Finally, Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $105.11.

View Our Latest Stock Analysis on CL

Colgate-Palmolive Trading Down 0.4 %

Shares of CL traded down $0.33 during mid-day trading on Tuesday, reaching $91.63. The stock had a trading volume of 300,028 shares, compared to its average volume of 4,356,058. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business’s fifty day moving average is $100.62 and its 200 day moving average is $98.52. Colgate-Palmolive has a 52-week low of $75.17 and a 52-week high of $109.30. The firm has a market cap of $74.86 billion, a price-to-earnings ratio of 26.36, a P/E/G ratio of 3.31 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.18%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.